Motley Fool  11 hrs ago  Comment 
Can these fast-rising biotech stocks keep the momentum going?
Motley Fool  Aug 9  Comment 
The company's second-quarter update is fueling optimism.
SeekingAlpha  Aug 8  Comment 
Motley Fool  Aug 7  Comment 
A game of musical chairs on its board of directors causes investors to sing a new tune about this beaten-down biotech.
Motley Fool  Jul 19  Comment 
Ziopharm has been stung by a series of clinical setbacks this year, and the company is now facing a serious cash crunch to boot.
Motley Fool  Jun 29  Comment 
Which beaten-down biotech stock wins in a head-to-head match-up?



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki